A Randomised Phase II Study of Pegylated Liposomal Doxorubicine in Elderly Patients with Acute Lymphoblastic Leukemia (ALL): The GRAALL-SA1 Study

被引:0
|
作者
Hunault-Berger, Mathilde
Leguay, Thibaut [1 ]
Thomas, Xavier [2 ]
Legrand, Ollivier [3 ]
Huguet, Francoise [4 ]
Witz, Francis [5 ]
Escoffre-Barbe, Martine [6 ]
Legros, Laurence [7 ]
Turlure, Pascal [8 ]
Chevallier, Patrice [9 ]
Larosa, Fabrice [10 ]
Cahn, Jean-Yves
Reman, Oumedaly [11 ]
Rousselot, Philippe [12 ,13 ]
Delannoy, Andre [14 ]
Dhedin, Nathalie [15 ]
Pochitaloff, Marina [16 ]
Bene, Marie-Christine
Ifrah, Norbert [17 ]
Dombret, Herve [18 ]
机构
[1] CH Bordeaux, Bordeaux, France
[2] GRAAL Grp, Lyon, France
[3] Hop Hotel Dieu, F-75181 Paris, France
[4] CHU Toulouse, Toulouse, France
[5] Hop Brabois, Nancy, France
[6] Hop Pontchaillou, Hematol Clin, Rennes, France
[7] CHU Nice, Nice, France
[8] CHU Limoges, Limoges, France
[9] CHU Hotel Dieu, Nantes, France
[10] CHU Jean Minjoz, INSERM, UMR645, Besancon, France
[11] CHU Caen, F-14000 Caen, France
[12] Hop Mignot, Versailles, France
[13] CIC9504, Versailles, France
[14] Hop Jolimont, Haine St Paul, Belgium
[15] Hop La Pitie Salpetriere, Serv Hematol Clin, Paris, France
[16] Cytogenet, Marseille, France
[17] CHU Angers, Serv Malad Sang, Angers, France
[18] Hop St Louis, AP HP, Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:340 / 340
页数:1
相关论文
共 50 条
  • [1] A RANDOMISED PHASE II STUDY OF PEGYLATED LIPOSOMAL DOXORUBICINE IN ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): THE GRAALL-SA1 STUDY
    Hunault-Berger, M.
    Leguay, T.
    Thomas, X.
    Legrand, O.
    Huguet, F.
    Witz, F.
    Chevallier, P.
    Escoffre-Barbe, M.
    Legros, L.
    Turlure, P.
    Larosa, F.
    Cahn, J. Y.
    Reman, O.
    Rousselot, P.
    Delannoy, A.
    Dhedin, N.
    Pochitaloff, M.
    Bene, M. C.
    Ifrah, N.
    Dombret, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 447 - 447
  • [2] A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study
    Hunault-Berger, Mathilde
    Leguay, Thibaut
    Thomas, Xavier
    Legrand, Ollivier
    Huguet, Francoise
    Bonmati, Caroline
    Escoffre-Barbe, Martine
    Legros, Laurence
    Turlure, Pascal
    Chevallier, Patrice
    Larosa, Fabrice
    Garban, Frederic
    Reman, Oumedaly
    Rousselot, Philippe
    Dhedin, Nathalie
    Delannoy, Andre
    Lafage-Pochitaloff, Marina
    Bene, Marie Christine
    Ifrah, Norbert
    Dombret, Herve
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 245 - 252
  • [3] Phase II study of liposomal vincristine (lipoV) in relapsed or refractory adult acute lymphoblastic leukemia (ALL).
    Thomas, DA
    Sarris, A
    O'Brien, S
    Cortes, J
    Giles, FJ
    Faderl, S
    Keating, MJ
    Burge, C
    Cabanillas, F
    Kantarjian, H
    BLOOD, 1999, 94 (10) : 238B - 238B
  • [4] A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study
    Hunault-Berger, Mathilde
    Leguay, Thibaut
    Huguet, Francoise
    Lepretre, Stephane
    Deconinck, Eric
    Ojeda-Uribe, Mario
    Bonmati, Caroline
    Escoffre-Barbe, Martine
    Bories, Pierre
    Himberlin, Chantal
    Chevallier, Patrice
    Rousselot, Philippe
    Reman, Oumedaly
    Boulland, Marie-Laure
    Lissandre, Severine
    Turlure, Pascal
    Bouscary, Didier
    Sanhes, Laurence
    Legrand, Ollivier
    Lafage-Pochitaloff, Marina
    Bene, Marie C.
    Liens, David
    Godfrin, Yann
    Ifrah, Norbert
    Dombret, Herve
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (09) : 811 - 818
  • [5] Phase II Study of Hyper-Cmad with Liposomal Vincristine (Marqibo) for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
    Sasaki, Koji
    Jabbour, Elias J.
    Khouri, Maria
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Short, Nicholas J.
    Issa, Ghayas C.
    Kadia, Tapan
    Jones, Emily
    Garris, Rebecca
    Cortes, Jorge E.
    O'Brien, Susan M.
    Kantarjian, Hagop M.
    BLOOD, 2017, 130
  • [6] A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia
    Tomlinson, Benjamin K.
    Tuscano, Joseph M.
    Abedi, Mehrdad
    Welborn, Jeanna
    Arora, Mili
    O'Donnell, Robert T.
    Wun, Ted
    Jonas, Brian A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (11) : E291 - E294
  • [7] Towards a pediatric approach in adults with acute lymphoblastic leukemia (ALL): The GRAALL-2003 study.
    Huguet, Francoise
    Raffoux, Emmanuel
    Thomas, Xavier
    Leguay, Thibaut
    Chevallier, Patrice
    Escoffre, Martine
    Reman, Oumedaly
    Caillot, Denis
    Vey, Norbert
    Boissel, Nicolas
    Hunault, Mathilde
    Buzyn, Agnes
    Chalandon, Yves
    Delannoy, Andre
    Vernant, Jean-Paul
    Lheritier, Veronique
    Bene, Marie-Christine
    Macintyre, Elizabeth
    Ifrah, Norbert
    Dombret, Herve
    BLOOD, 2006, 108 (11) : 48A - 48A
  • [8] Phase II study of hyper-CMAD with Liposomal Vincristine (Marqibo) for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia
    Sasaki, Koji
    Jabbour, Elias
    O'Brien, Susan
    Thomas, Deborah
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Short, Nicholas
    Issa, Ghayas
    Gachimova, Evguenia
    Garris, Rebecca
    Cortes, Jorge
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S266 - S266
  • [9] A phase II study of a high intensity regimen in the treatment of acute lymphoblastic leukemia (ALL).
    Nair, SM
    Saba, HI
    Wetzstein, GA
    Speirs, ASA
    Balducci, L
    Zuckerman, KS
    Turnquest, TA
    Loughran, T
    BLOOD, 2001, 98 (11) : 218B - 218B
  • [10] Liposomal daunorubicin (Daunoxome®) for childhood acute lymphoblastic leukemia:: A phase I-II study.
    Baruchel, A
    Auvrignon, A
    Perel, Y
    Leblanc, T
    Landman, J
    Bertrand, Y
    Gandemer, V
    Mechinaud, F
    Michel, G
    Robert, J
    Leverger, G
    Schaison, G
    BLOOD, 1998, 92 (10) : 234A - 234A